Deutsche Bank’s SBC Medical Group SBC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$57.9K Buy
+18,783
New +$63.7K ﹤0.01% 3555
2025
Q3
Sell
-7,236
Closed -$33.6K 3763
2025
Q2
$33.6K Buy
+7,236
New +$28.6K ﹤0.01% 3451
2024
Q1
Sell
-13,533
Closed -$144K 3680
2023
Q4
$144K Hold
13,533
﹤0.01% 3041
2023
Q3
$145K Buy
+13,533
New +$143K ﹤0.01% 2982
2023
Q2
Sell
-121,521
Closed -$1.27M 3963
2023
Q1
$1.27M Hold
121,521
﹤0.01% 1951
2022
Q4
$1.24M Buy
+121,521
New +$1.23M ﹤0.01% 1917

Other funds holding SBC

Deutsche Bank's SBC Position: Q2 2026 in Review

Deutsche Bank opened a new position in SBC Medical Group (SBC) in Q2 2026: 18,783 shares worth $57.9K. The stake represents ﹤0.01% of the portfolio and ranks #3555 among its holdings. This is a return to the name: Deutsche Bank previously reported a position in SBC as recently as Q2 2025.

Deutsche Bank first reported a position in SBC in Q4 2022 and has held it in 6 quarters since. The position peaked at $1.27M in Q1 2023. 56 funds tracked by Wall St. Rank hold SBC as of Q2 2026.

  • Deutsche Bank held 18,783 shares of SBC Medical Group worth $57.9K as of Q2 2026.
  • SBC Medical Group was a new Deutsche Bank position in Q2 2026.
  • SBC Medical Group made up ﹤0.01% of Deutsche Bank's portfolio in Q2 2026, its #3555 holding.
  • Deutsche Bank first reported a position in SBC Medical Group in Q4 2022 and has held it in 6 quarters since.
  • Deutsche Bank's SBC Medical Group position peaked at $1.27M in Q1 2023.
  • 56 funds tracked by Wall St. Rank held SBC Medical Group as of Q2 2026.

Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.